Alnylam Pharmaceuticals (United States), 2024. Rna Interference Therapeutic Zilebesiran:, Alnylam Pharmaceuticals (United States).
United States of America
Retrieved from https://coilink.org/20.500.12592/bi91fqd on 15 Nov 2024. COI: 20.500.12592/bi91fqd.
Download citation (RIS)